Annual EBITDA
$368.26M$320.30M-46.52%
Summary
- Current Value
- As of today, QGEN annual EBITDA is $368.26M, down -46.52% on
- Historical Performance
- QGEN annual EBITDA is down -58.87% over the past 3 years, and up +61.61% over the past 5 years
- All-Time High Comparison
- QGEN annual EBITDA is currently -58.87% below its historical high of $895.24M set on
- 3-Year Low Comparison
- QGEN annual EBITDA is at its 3-year low
- Sector Comparison
- QGEN annual EBITDA is higher than 90.16% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $368.26M | -46.5% | -58.9% | +61.6% | +14.2% | |
| Quarterly EBITDA | $188.26M | +4.9% | +8.1% | -5.9% | +119.3% | |
| TTM EBITDA | $734.13M | +7.8% | -13.5% | +7.0% | +130.2% | |
| Price | $49.80 | +1.6% | -10.8% | -14.6% | +122.4% | |
| PE Ratio | 26.87 | -79.6% | -8.7% | -26.0% | -22.9% | |
| Annual Revenue | $1.98B | +0.7% | -12.1% | +29.6% | +95.9% | |
| Annual EPS | $0.38 | -74.9% | -83.2% | +303.1% | -44.6% | |
| Annual EBIT | $164.99M | -65.9% | -75.8% | +4694.5% | -18.3% | |
| Annual Net Income | $83.59M | -75.5% | -83.7% | +301.6% | -39.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $779.36M | N/A | -52.8% |
| 5Y | $895.24M | -58.9% | |
| All | $895.24M | -58.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $368.26M | at low | |
| 5Y | $368.26M | at low | |
| All | $6.50M | +5565.5% |
EBITDA History
FAQ
What is the current annual EBITDA of QGEN?
As of today, QGEN annual EBITDA is $368.26M
What is 1-year change in QGEN annual EBITDA?
QGEN annual EBITDA is down -46.52% year-over-year
What is 3-year change in QGEN annual EBITDA?
QGEN annual EBITDA is down -58.87% over the past 3 years
How far is QGEN annual EBITDA from its all-time high?
QGEN annual EBITDA is currently -58.87% below its historical high of $895.24M set on December 31, 2021
How does QGEN annual EBITDA rank versus sector peers?
QGEN annual EBITDA is higher than 90.16% of companies in Healthcare sector
When is QGEN next annual earnings release?
The next annual earnings release for QGEN is on
Quarterly EBITDA
$188.26M$2.81M+1.51%
Summary
- Current Value
- As of today, QGEN quarterly EBITDA is $188.26M, up +1.51% on
- Historical Performance
- QGEN quarterly EBITDA is up +4.93% year-over-year, and up +8.08% over the past 3 years
- All-Time High Comparison
- QGEN quarterly EBITDA is currently -29.18% below its historical high of $265.82M set on
- 3-Year Low Comparison
- QGEN quarterly EBITDA is +23.39% above its 3-year low of $152.58M reached on
- Sector Comparison
- QGEN quarterly EBITDA is higher than 91.42% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $188.26M | +1.5% | +4.9% | +8.1% | -5.9% | |
| Annual EBITDA | $368.26M | – | -46.5% | -58.9% | +61.6% | |
| TTM EBITDA | $734.13M | +1.2% | +7.8% | -13.5% | +7.0% | |
| Price | $49.80 | -0.9% | +1.6% | -10.8% | -14.6% | |
| PE Ratio | 26.87 | -0.9% | -79.6% | -8.7% | -26.0% | |
| Quarterly Revenue | $532.58M | -0.2% | +6.1% | +6.6% | +10.1% | |
| Quarterly EPS | $0.60 | +35.0% | +36.0% | +61.2% | +705.5% | |
| Quarterly EBIT | $137.29M | +1.0% | +6.1% | +10.8% | -8.1% | |
| Quarterly Net Income | $130.04M | +35.1% | +32.6% | +57.8% | +669.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $190.03M | N/A | -0.9% |
| 3Y | $190.03M | -0.9% | |
| 5Y | $265.82M | -29.2% | |
| All | $265.82M | -29.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $170.39M | +10.5% | |
| 3Y | $152.58M | +23.4% | |
| 5Y | $152.58M | +23.4% | |
| All | -$33.20M | +667.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of QGEN?
As of today, QGEN quarterly EBITDA is $188.26M
What is QGEN quarterly EBITDA most recent change?
QGEN quarterly EBITDA was up +1.51% on September 30, 2025
What is 1-year change in QGEN quarterly EBITDA?
QGEN quarterly EBITDA is up +4.93% year-over-year
How far is QGEN quarterly EBITDA from its all-time high?
QGEN quarterly EBITDA is currently -29.18% below its historical high of $265.82M set on March 31, 2022
How does QGEN quarterly EBITDA rank versus sector peers?
QGEN quarterly EBITDA is higher than 91.42% of companies in Healthcare sector
When is QGEN next earnings release?
The next earnings release for QGEN is on
TTM EBITDA
$734.13M$8.84M+1.22%
Summary
- Current Value
- As of today, QGEN TTM EBITDA is $734.13M, up +1.22% on
- Historical Performance
- QGEN TTM EBITDA is up +7.76% year-over-year, and down -13.52% over the past 3 years
- All-Time High Comparison
- QGEN TTM EBITDA is currently -20.19% below its historical high of $919.82M set on
- 3-Year Low Comparison
- QGEN TTM EBITDA is +13.85% above its 3-year low of $644.82M reached on
- Sector Comparison
- QGEN TTM EBITDA is higher than 91.96% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $734.13M | +1.2% | +7.8% | -13.5% | +7.0% | |
| Annual EBITDA | $368.26M | – | -46.5% | -58.9% | +61.6% | |
| Quarterly EBITDA | $188.26M | +1.5% | +4.9% | +8.1% | -5.9% | |
| Price | $49.80 | -0.9% | +1.6% | -10.8% | -14.6% | |
| PE Ratio | 26.87 | -0.9% | -79.6% | -8.7% | -26.0% | |
| TTM Revenue | $2.07B | +1.5% | +5.3% | -7.0% | +20.9% | |
| TTM EPS | $1.85 | +9.3% | +359.1% | -10.6% | +119.0% | |
| TTM EBIT | $544.22M | +1.5% | +15.3% | -15.5% | +12.1% | |
| TTM Net Income | $405.37M | +8.6% | +336.2% | -12.6% | +111.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $734.13M | at high | |
| 3Y | $784.63M | N/A | -6.4% |
| 5Y | $919.82M | -20.2% | |
| All | $919.82M | -20.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $698.23M | N/A | +5.1% |
| 3Y | $644.82M | +13.8% | |
| 5Y | $644.82M | +13.8% | |
| All | -$27.00M | +2819.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of QGEN?
As of today, QGEN TTM EBITDA is $734.13M
What is QGEN TTM EBITDA most recent change?
QGEN TTM EBITDA was up +1.22% on September 30, 2025
What is 1-year change in QGEN TTM EBITDA?
QGEN TTM EBITDA is up +7.76% year-over-year
How far is QGEN TTM EBITDA from its all-time high?
QGEN TTM EBITDA is currently -20.19% below its historical high of $919.82M set on March 31, 2022
How does QGEN TTM EBITDA rank versus sector peers?
QGEN TTM EBITDA is higher than 91.96% of companies in Healthcare sector
When is QGEN next earnings release?
The next earnings release for QGEN is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- QGEN Official Website www.qiagen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1015820/000101582025000074/0001015820-25-000074-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1015820/000101582025000027/0001015820-25-000027-index.htm
- QGEN Profile on Yahoo Finance finance.yahoo.com/quote/QGEN
- QGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/qgen